Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

por Pai, Menaka, Adhikari, Neill K. J., Ostermann, Marlies, Heels-Ansdell, Diane, Douketis, James D., Skrobik, Yoanna, Qushmaq, Ismael, Meade, Maureen, Guyatt, Gordon, Geerts, William, Walsh, Michael W., Crowther, Mark A., Friedrich, Jan O., Burry, Lisa, Bellomo, Rinaldo, Brandão da Silva, Nilton, Costa Filho, Rubens, Cox, Michael J., Alves Silva, Suzana, Cook, Deborah J.
Publicado 2018